Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Acute Intermittent Hypoxia (AIH) is a rehab approach attributed to serotonin. AIH signaling also occurs via adenosine, and the pathways inhibit each other. Increased neural adenosine in aging may stymie AIH plasticity. The hypothesis is pre-treatment with adenosine 2A receptor inhibition (A2AI) enhances AIH effects on motor plasticity in unaffected adults. AIH exposures will be paired with A2AI or placebo, with a 4-week washout. Primary outcome measures include inspiratory and grip strength.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| AIH + placebo | Placebo Comparator | Participants will receive a methylcellulose capsule identical in appearance to the experimental treatment, followed by acute intermittent hypoxia |
|
| AIH + Istradefylline | Experimental | Participants will receive 20 mg, followed by acute intermittent hypoxia |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Istradefylline 20 mg | Drug | Participants will receive 20 mg istradefylline active treatment, followed by acute intermittent hypoxia |
|
| Measure | Description | Time Frame |
|---|---|---|
| Maximal Inspiratory Pressure | Most negative pressure generated during a maximal inspiratory effort. | From enrollment to a 3-week follow-up. |
| Maximal grip force | Highest tension generated by the flexor muscles of the hand during a maximal grip. | From enrollment to a 3-week follow up. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ushna Khan, MD | Contact | 352-273-6855 | ushnakhan@ufl.edu |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| C111599 | istradefylline |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo | Drug | Participants will receive a methylcellulose capsule identical in appearance to the active treatment, followed by acute intermittent hypoxia |
|
| Acute Intermittent Hypoxia (AIH) | Other | Short periods (~1 minute) of breathing lower-oxygen gas, separated by periods (~1 minute) of breathing normal oxygen air. |
|